Dr Springman is the Founder & President of Illuma Biosciences. Through his company, he assists academic innovators, independent IP holders and early-stage biotech companies in bringing their concepts from the page to clinical proof-of-concept. His current clients span a range of therapeutic and diagnostic areas including cancer, fibrosis, immunology and inflammatory conditions.During his 25-year industry career, Dr Springman has brought many new investigational medicines from discovery to clinic in disease conditions ranging from inflammation and fibrosis to osteoporosis and cancer. He completed his postdoctoral training in Clinical Pharmacology and Immunology at Vanderbilt University School of Medicine, where he was an American Lung Association Research Fellow. He holds a PhD in Molecular Biophysics from Florida State University, where his graduate work was presented at the 1998 Nobel Mini-Forum. Dr Springman is a past member of the Pennsylvania Drug, Device and Cosmetics Board and the GABIO Board of Directors.For details of Dr Springman's publications, please see the ResearchGate link in the "Featured" section.